XML 21 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
RESTATEMENT AND REVISION OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS
12 Months Ended
Dec. 31, 2021
RESTATEMENT AND REVISION OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS  
RESTATEMENT AND REVISION OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 3 – RESTATEMENT AND REVISION OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS

The Company identified errors in its previously issued annual and interim financial statements that required restatements, as well as errors that were determined individually, and in the aggregate, quantitatively and qualitatively immaterial that required revisions.  As such the Company has restated and revised its (i) consolidated financial statements as of and for the years ended December 31, 2021, 2020 and 2019 as illustrated in this note to the consolidated financial statements; and (ii) consolidated interim financial statements for the three months ended March 31, 2021, the three and six months ended June 30, 2021, and the three and nine months ended September 30, 2021, as illustrated in Note 16; collectively referred to as the “Restatement” or “Revision”.

During the three month period ended June 30, 2022, the Company identified areas of restatement errors. Adjustments depicted in the tables below relate to the following:

(a)an error in the accounting treatment regarding the overcapitalization of internally allocated construction related costs related to the development project at 77 Greenwich Street;  
(b)a disclosure error in the classification on the balance sheets of our 77 Greenwich property which was classified as real estate under development in real estate and is now classified as residential condominium units for sale;
(c)a disclosure error in the classification on the statements of cash flows of our 77 Greenwich property relating to  additions and sales of condominiums where they were reported in the statement of cash flows under cash flows from investing activities when they should have been reported in cash flows from operations.  

During the three month period ended March 31, 2022, the Company identified one revision error. Adjustments depicted in the tables below relate to the following:

(d)an error in the accounting treatment of a property that, upon emergence from bankruptcy, was classified as real estate under development, but was not subsequently reported as an operating property when circumstances at the property changed.

During the year ended December 31, 2021, the Company identified one revision error. Adjustments depicted in the tables below relate to the following:

(e)an error in the accounting treatment regarding certain advertising and marketing costs which were capitalized to construction costs at the development project at 77 Greenwich Street and should have been expensed as incurred.  

CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE LOSS

(In thousands, except share amounts)

For the Year Ended December 31, 2019

As Previously

Revision

    

Reported

    

Impact

    

As Revised

Revenues

Rental revenues

$

4,062

$

569

$

4,631

Total revenues

4,062

569

4,631

Operating Expenses

Property operating expenses

5,328

1,812

7,140

Real estate taxes

328

182

510

General and administrative

5,349

328

5,677

Pension related costs

733

733

Transaction related costs

167

167

Depreciation and amortization

2,977

1,141

4,118

Total operating expenses

14,882

3,463

18,345

Gain on sale of real estate

9,521

9,521

Operating loss

(1,299)

(2,894)

(4,193)

Equity in net loss from unconsolidated joint ventures

(819)

(819)

Interest income (expense), net

67

(180)

(113)

Interest expense - amortization of deferred finance costs

(39)

(39)

Loss before taxes

(2,051)

(3,113)

(5,164)

Tax expense

(128)

(128)

Net loss attributable to common stockholders

$

(2,179)

$

(3,113)

$

(5,292)

Other comprehensive loss:

Unrealized gain on pension liability

344

344

Comprehensive loss attributable to common stockholders

$

(1,835)

$

(3,113)

$

(4,948)

Loss per share - basic and diluted

$

(0.07)

$

(0.10)

$

(0.17)

Weighted average number of common shares - basic and diluted

31,915

31,915

31,915

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands)

FOR THE YEAR ENDED DECMEBER 31, 2019

Accumulated

Additional

Other

Common Stock

Paid-In

Treasury Stock

Accumulated

Comprehensive

    

Shares

    

Amount

    

Capital

    

Shares

    

Amount

    

Deficit

    

Loss

    

Total

As Previously Reported

Balance as of December 31, 2018

37,161

$

372

$

132,831

(5,514)

$

(54,758)

$

(15,466)

$

(3,518)

$

59,461

Net loss attributable to common stockholders

(2,179)

(2,179)

Settlement of stock awards

451

4

(187)

(776)

(772)

Unrealized gain on pension liability

1,648

344

1,992

Stock-based compensation expense

1,386

1,386

Stock buy-back

(30)

(197)

(197)

Balance as of December 31, 2019

37,612

$

376

$

134,217

(5,731)

$

(55,731)

$

(15,997)

$

(3,174)

$

59,691

Revision Impact

Balance as of December 31, 2018

$

$

$

$

(614)

$

$

(614)

Net loss attributable to common stockholders

(3,113)

(3,113)

Settlement of stock awards

Unrealized gain on pension liability

Stock-based compensation expense

Stock buy-back

Balance as of December 31, 2019

$

$

$

$

(3,727)

$

$

(3,727)

As Revised

Balance as of December 31, 2018

37,161

$

372

$

132,831

(5,514)

$

(54,758)

$

(16,080)

$

(3,518)

$

58,847

Net loss attributable to common stockholders

(5,292)

(5,292)

Settlement of stock awards

451

4

(187)

(776)

(772)

Unrealized gain on pension liability

1,648

344

1,992

Stock-based compensation expense

1,386

1,386

Stock buy-back

(30)

(197)

(197)

Balance as of December 31, 2019

37,612

$

376

$

134,217

(5,731)

$

(55,731)

$

(19,724)

$

(3,174)

$

55,964

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

For the Year Ended December 31, 2019

As Previously

Restatement

    

Reported

    

Impact

    

As Restated

CASH FLOWS FROM OPERATING ACTIVITIES:

Net loss attributable to common stockholders

$

(2,179)

$

(3,113)

$

(5,292)

Adjustments to reconcile net loss attributable to common stockholders to net cash used in operating activities:

Depreciation and amortization and amortization of deferred finance costs

2,977

1,180

4,157

Stock-based compensation expense

905

905

Gain on sale of real estate

(9,521)

(9,521)

Deferred rents receivable

578

578

Other non-cash adjustments - pension expense

1,992

1,992

Equity in net loss from unconsolidated joint ventures

819

819

Distributions from unconsolidated joint ventures

33

33

Decrease (increase) in operating assets:

Residential condominium units for sale

(65,098)

(65,098)

Receivables

1,577

1,577

Prepaid expenses and other assets, net

278

278

Increase (decrease) in operating liabilities:

Accounts payable and accrued expenses

1,649

1,649

Pension liabilities

(2,705)

(2,705)

Net cash used in operating activities

(3,597)

(67,031)

(70,628)

CASH FLOWS FROM INVESTING ACTIVITIES:

Additions to real estate

(91,847)

67,031

(24,816)

Net proceeds from the sale of real estate

18,812

18,812

Deferred real estate deposits of SCA condominium

33,609

33,609

Net cash used in (provided by) investing activities

(39,426)

67,031

27,605

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from loans and corporate credit facility

55,475

55,475

Proceeds from secured line of credit

7,250

7,250

Payment of finance costs

(1,531)

(1,531)

Repayment of loans

(10,557)

(10,557)

Repayment of secured line of credit

(2,000)

(2,000)

Settlement of stock awards

(772)

(772)

Stock buy-back

(197)

(197)

Net cash provided by financing activities

47,668

47,668

NET DECREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH

4,645

4,645

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD

14,025

14,025

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD

$

18,670

$

$

18,670

CASH AND CASH EQUIVALENTS, BEGINNING PERIOD

$

11,496

$

$

11,496

RESTRICTED CASH, BEGINNING OF PERIOD

2,529

2,529

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD

$

14,025

$

$

14,025

CASH AND CASH EQUIVALENTS, END OF PERIOD

$

9,196

$

$

9,196

RESTRICTED CASH, END OF PERIOD

9,474

9,474

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD

$

18,670

$

$

18,670

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

Cash paid during the period for: Interest

$

12,631

$

$

12,631

Cash paid during the period for: Taxes

$

352

$

$

352

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:

Accrued development costs included in accounts payable and accrued expenses

$

12,698

$

(12,698)

$

Capitalized amortization of deferred financing costs and warrants

$

2,739

$

(39)

$

2,700

Capitalized stock-based compensation expense

$

480

$

(79)

$

401

Right of use asset

$

1,904

$

$

1,904

Lease liabilities

$

(2,065)

$

$

(2,065)

Warrant liability

$

(1,795)

$

$

(1,795)

CONSOLIDATED BALANCE SHEETS

(In thousands, except par value and share amounts)

As of December 31, 2020

As Previously

Restatement

    

Reported

    

Impact

    

As Restated

ASSETS

Real estate, net

$

279,204

$

(209,164)

$

70,040

Residential condominium units for sale

203,276

203,276

Cash and cash equivalents

6,515

6,515

Restricted cash

9,554

9,554

Prepaid expenses and other assets, net

2,703

2,703

Investments in unconsolidated joint ventures

19,379

19,379

Receivables

966

966

Deferred rents receivable

90

90

Right-of-use asset

1,565

1,565

Intangible assets, net

9,172

9,172

Total assets

$

329,148

$

(5,888)

$

323,260

LIABILITIES

Loans payable, net

$

197,330

$

$

197,330

Corporate credit facility, net

31,858

31,858

Secured line of credit, net

7,747

7,747

Note payable

5,863

5,863

Accounts payable and accrued expenses

15,896

15,896

Lease liability

1,716

1,716

Warrant liability

830

830

Total liabilities

261,240

261,240

Commitments and Contingencies

STOCKHOLDERS' EQUITY

Preferred stock, $0.01 par value; 40,000,000 shares authorized; no shares issued and outstanding

Preferred stock, $0.01 par value; 2 shares authorized, no shares issued and outstanding at December 31, 2020

Special stock, $0.01 par value; 1 share authorized, issued and outstanding at December 31, 2020

Common stock, $0.01 par value; 79,999,997 shares authorized; 38,345,540 shares issued at December 31, 2020; 32,172,107 shares outstanding at December 31, 2020

383

383

Additional paid-in capital

135,978

135,978

Treasury stock (6,173,433 shares at December 31, 2020)

(56,791)

(56,791)

Accumulated other comprehensive loss

(2,159)

(2,159)

Accumulated deficit

(9,503)

(5,888)

(15,391)

Total stockholders' equity

67,908

(5,888)

62,020

Total liabilities and stockholders' equity

$

329,148

$

(5,888)

$

323,260

CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE INCOME

(In thousands, except share amounts)

For the Year Ended December 31, 2020

As Previously

Revision

    

Reported

    

Impact

    

As Revised

Revenues

Rental revenues

$

993

$

570

$

1,563

Other income

263

263

Total revenues

1,256

570

1,826

Operating Expenses

Property operating expenses

8,166

954

9,120

Real estate taxes

79

175

254

General and administrative

4,955

262

5,217

Pension related costs

345

345

Transaction related costs

133

133

Depreciation and amortization

2,768

1,139

3,907

Total operating expenses

16,446

2,530

18,976

Gain on sale of school condominium

24,196

24,196

Operating income

9,006

(1,960)

7,046

Equity in net loss from unconsolidated joint ventures

(1,571)

(1,571)

Unrealized gain on warrants

965

965

Interest expense, net

(1,398)

(142)

(1,540)

Interest expense - amortization of deferred finance costs

(202)

(59)

(261)

Income before taxes

6,800

(2,161)

4,639

Tax expense

(306)

(306)

Net income attributable to common stockholders

$

6,494

$

(2,161)

$

4,333

Other comprehensive income:

Unrealized gain on pension liability

1,015

1,015

Comprehensive income attributable to common stockholders

$

7,509

$

(2,161)

$

5,348

Income per share - basic

$

0.20

$

(0.07)

$

0.13

Income per share - diluted

$

0.20

$

(0.07)

$

0.13

Weighted average number of common shares - basic

32,305

32,305

32,305

Weighted average number of common shares - diluted

32,860

32,860

32,860

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands)

FOR THE YEAR ENDED DECMEBER 31, 2020

Accumulated

Additional

Other

Common Stock

Paid-In

Treasury Stock

Accumulated

Comprehensive

    

Shares

    

Amount

    

Capital

    

Shares

    

Amount

    

Deficit

    

Loss

    

Total

As Previously Reported

Balance as of December 31, 2019

37,612

$

376

$

134,217

(5,731)

$

(55,731)

$

(15,997)

$

(3,174)

$

59,691

Net income attributable to common stockholders

6,494

6,494

Settlement of stock awards

543

5

(222)

(701)

(696)

Unrealized gain on pension liability

1,015

1,015

Stock-based compensation expense

1,163

1,163

Stock-based consulting fees

190

2

598

600

Stock buy-back

(220)

(359)

(359)

Balance as of December 31, 2020

38,345

$

383

$

135,978

(6,173)

$

(56,791)

$

(9,503)

$

(2,159)

$

67,908

Revision Impact

Balance as of December 31, 2019

$

$

$

$

(3,727)

$

$

(3,727)

Net loss attributable to common stockholders

(2,161)

(2,161)

Settlement of stock awards

Unrealized gain on pension liability

Stock-based compensation expense

Stock-based consulting fees

Stock buy-back

Balance as of December 31, 2020

$

$

$

$

(5,888)

$

$

(5,888)

As Revised

Balance as of December 31, 2019

37,612

$

376

$

134,217

(5,731)

$

(55,731)

$

(19,724)

$

(3,174)

$

55,964

Net income attributable to common stockholders

4,333

4,333

Settlement of stock awards

543

5

(222)

(701)

(696)

Unrealized gain on pension liability

1,015

1,015

Stock-based compensation expense

1,163

1,163

Stock-based consulting fees

190

2

598

600

Stock buy-back

(220)

(359)

(359)

Balance as of December 31, 2020

38,345

$

383

$

135,978

(6,173)

$

(56,791)

$

(15,391)

$

(2,159)

$

62,020

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

For the Year Ended December 31, 2020

As Previously

Restatement

    

Reported

    

Impact

    

As Restated

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income attributable to common stockholders

$

6,494

$

(2,161)

$

4,333

Adjustments to reconcile net income attributable to common stockholders to net cash used in operating activities:

Depreciation and amortization and amortization of deferred finance costs

2,970

1,198

4,168

Stock-based compensation expense

806

806

Gain on sale of school condominium

(24,196)

(24,196)

Deferred rents receivable

(84)

(84)

Other non-cash adjustments - pension expense

1,015

1,015

Unrealized gain on warrants

(965)

(965)

Equity in net loss from unconsolidated joint ventures

1,571

1,571

Distributions from unconsolidated joint ventures

1,110

1,110

Decrease in operating assets:

Residential condominium units for sale

(46,473)

(46,473)

Receivables

2,392

2,392

Prepaid expenses and other assets, net

190

190

(Decrease) increase in operating liabilities:

Accounts payable and accrued expenses

(686)

1,971

1,285

Pension liabilities

(1,033)

(1,033)

Net cash used in operating activities

(10,416)

(45,465)

(55,881)

CASH FLOWS FROM INVESTING ACTIVITIES:

Additions to real estate

(51,715)

47,436

(4,279)

Deferred real estate deposits of condominiums

1,971

(1,971)

Investments in unconsolidated joint ventures

(5,383)

(5,383)

Net cash used in investing activities

(55,127)

45,465

(9,662)

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from loans and corporate credit facility

86,361

86,361

Proceeds from secured line of credit

5,000

5,000

Payment of finance costs

(1,497)

(1,497)

Repayment of loans

(23,368)

(23,368)

Repayment of secured line of credit

(2,500)

(2,500)

Settlement of stock awards

(695)

(695)

Stock buy-back

(359)

(359)

Net cash provided by financing activities

62,942

62,942

NET DECREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH

(2,601)

(2,601)

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD

18,670

18,670

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD

$

16,069

$

$

16,069

CASH AND CASH EQUIVALENTS, BEGINNING PERIOD

$

9,196

$

$

9,196

RESTRICTED CASH, BEGINNING OF PERIOD

9,474

9,474

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD

$

18,670

$

$

18,670

CASH AND CASH EQUIVALENTS, END OF PERIOD

$

6,515

$

$

6,515

RESTRICTED CASH, END OF PERIOD

9,554

9,554

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD

$

16,069

$

$

16,069

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

Cash paid during the period for: Interest

$

15,495

$

$

15,495

Cash paid during the period for: Taxes

$

251

$

$

251

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:

Accrued development costs included in accounts payable and accrued expenses

$

10,319

$

(10,319)

$

Capitalized amortization of deferred financing costs and warrants

$

2,727

$

(59)

$

2,668

Capitalized stock-based compensation expense

$

356

$

(57)

$

299

Investment in unconsolidated joint venture

$

5,193

$

$

5,193

CONSOLIDATED BALANCE SHEETS

(In thousands, except par value and share amounts)

As of December 31, 2021

As Previously

Restatement

    

Reported

    

Impact

    

As Restated

ASSETS

Real estate, net

$

294,536

$

(227,202)

$

67,334

Residential condominium units for sale

216,983

216,983

Cash and cash equivalents

4,310

4,310

Restricted cash

20,535

20,535

Prepaid expenses and other assets, net

4,126

4,126

Investments in unconsolidated joint ventures

17,938

17,938

Receivables

84

84

Deferred rents receivable

114

114

Right-of-use asset

1,314

1,314

Intangible assets, net

8,432

8,432

Total assets

$

351,389

$

(10,219)

$

341,170

LIABILITIES

Loans payable, net

$

219,249

$

$

219,249

Corporate credit facility, net

32,844

32,844

Secured line of credit, net

12,750

12,750

Note payable

5,863

5,863

Accounts payable and accrued expenses

17,864

17,864

Lease liability

1,447

1,447

Warrant liability

1,146

1,146

Total liabilities

291,163

291,163

Commitments and Contingencies

STOCKHOLDERS' EQUITY

Preferred stock, $0.01 par value; 40,000,000 shares authorized; no shares issued and outstanding

Preferred stock, $0.01 par value; 2 shares authorized, no shares issued and outstanding at December 31, 2021

Special stock, $0.01 par value; 1 share authorized, issued and outstanding at December 31, 2021

Common stock, $0.01 par value; 79,999,997 shares authorized; 43,024,424 shares issued at December 31, 2021; 36,626,549 shares outstanding at December 31, 2021

430

430

Additional paid-in capital

144,282

144,282

Treasury stock (6,397,875 shares at December 31, 2021)

(57,166)

(57,166)

Accumulated other comprehensive loss

(1,343)

(1,343)

Accumulated deficit

(25,977)

(10,219)

(36,196)

Total stockholders' equity

60,226

(10,219)

50,007

Total liabilities and stockholders' equity

$

351,389

$

(10,219)

$

341,170

CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE LOSS

(In thousands, except share amounts)

For the Year Ended December 31, 2021

As Previously

Restatement

    

Reported

    

Impact

    

As Restated

Revenues

Rental revenues

$

2,600

$

625

$

3,225

Other income

355

355

Sale of residential condominium units

24,802

(1,117)

23,685

Total revenues

27,757

(492)

27,265

Operating Expenses

Property operating expenses

7,414

(1,831)

5,583

Real estate taxes

74

650

724

General and administrative

4,492

641

5,133

Pension related costs

67

67

Cost of sale - residential condominium units

24,432

(2,062)

22,370

Depreciation and amortization

2,864

1,139

4,003

Total operating expenses

39,343

(1,463)

37,880

Operating loss

(11,586)

971

(10,615)

Equity in net loss from unconsolidated joint ventures

(555)

(555)

Unrealized gain on warrants

73

73

Interest expense, net

(3,007)

(4,915)

(7,922)

Interest expense - amortization of deferred finance costs

(1,134)

(387)

(1,521)

Loss before taxes

(16,209)

(4,331)

(20,540)

Tax expense

(265)

(265)

Net loss attributable to common stockholders

$

(16,474)

$

(4,331)

$

(20,805)

Other comprehensive loss:

Unrealized gain on pension liability

816

816

Comprehensive loss attributable to common stockholders

$

(15,658)

$

(4,331)

$

(19,989)

Loss per share - basic and diluted

$

(0.49)

$

(0.13)

$

(0.62)

Weighted average number of common shares - basic and diluted

33,322

33,322

33,322

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands)

FOR THE YEAR ENDED DECEMBER 31, 2021

Accumulated

Additional

Other

Common Stock

Paid-In

Treasury Stock

Accumulated

Comprehensive

    

Shares

    

Amount

    

Capital

    

Shares

    

Amount

    

Deficit

    

Loss

    

Total

As Previously Reported

Balance as of December 31, 2020

38,345

$

383

$

135,978

(6,173)

$

(56,791)

$

(9,503)

$

(2,159)

$

67,908

Net loss attributable to common stockholders

(16,474)

(16,474)

Settlement of stock awards

535

5

(225)

(375)

(370)

Unrealized gain on pension liability

816

816

Sale of common stock

4,144

42

7,597

7,639

Stock-based compensation expense

707

707

Balance as of December 31, 2021

43,024

$

430

$

144,282

(6,398)

$

(57,166)

$

(25,977)

$

(1,343)

$

60,226

Restatement Impact

Balance as of December 31, 2020

$

$

$

$

(5,888)

$

$

(5,888)

Net loss attributable to common stockholders

(4,331)

(4,331)

Settlement of stock awards

Unrealized gain on pension liability

Sale of common stock

Stock-based compensation expense

Balance as of December 31, 2021

$

$

$

$

(10,219)

$

$

(10,219)

As Restated

Balance as of December 31, 2020

38,345

$

383

$

135,978

(6,173)

$

(56,791)

$

(15,391)

$

(2,159)

$

62,020

Net loss attributable to common stockholders

(20,805)

(20,805)

Settlement of stock awards

535

5

(225)

(375)

(370)

Unrealized gain on pension liability

816

816

Sale of common stock

4,144

42

7,597

7,639

Stock-based compensation expense

707

707

Balance as of December 31, 2021

43,024

$

430

$

144,282

(6,398)

$

(57,166)

$

(36,196)

$

(1,343)

$

50,007

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

For the Year Ended December 31, 2021

As Previously

Restatement

    

Reported

    

Impact

    

As Restated

CASH FLOWS FROM OPERATING ACTIVITIES:

Net loss attributable to common stockholders

$

(16,474)

$

(4,331)

$

(20,805)

Adjustments to reconcile net loss attributable to common stockholders to net cash used in operating activities:

Depreciation and amortization and amortization of deferred finance costs

3,998

1,526

5,524

Stock-based compensation expense

530

530

Deferred rents receivable

(24)

(24)

Other non-cash adjustments - pension expense

816

816

Unrealized gain on warrants

(73)

(73)

Equity in net loss from unconsolidated joint ventures

555

555

Distributions from unconsolidated joint ventures

885

885

(Increase) decrease in operating assets:

Residential condominium units for sale

(321)

(11,129)

(11,450)

Receivables

882

882

Prepaid expenses and other assets, net

(257)

(257)

Increase (decrease) in operating liabilities:

Accounts payable and accrued expenses

3,467

3,467

Pension liabilities

(1,288)

(1,288)

Net cash used in operating activities

(7,304)

(13,934)

(21,238)

CASH FLOWS FROM INVESTING ACTIVITIES:

Additions to real estate

(36,349)

36,209

(140)

Net proceeds from the sale of residential condominium units

22,275

(22,275)

Net cash used in investing activities

(14,074)

13,934

(140)

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from loans and corporate credit facility

249,984

249,984

Proceeds from secured line of credit

8,200

8,200

Payment of finance costs

(6,552)

(6,552)

Repayment of loans

(225,547)

(225,547)

Repayment of secured line of credit

(3,200)

(3,200)

Settlement of stock awards

(370)

(370)

Sale of common stock, net

7,639

7,639

Net cash provided by financing activities

30,154

30,154

NET INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH

8,776

8,776

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD

16,069

16,069

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD

$

24,845

$

$

24,845

CASH AND CASH EQUIVALENTS, BEGINNING PERIOD

$

6,515

$

$

6,515

RESTRICTED CASH, BEGINNING OF PERIOD

9,554

9,554

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD

$

16,069

$

$

16,069

CASH AND CASH EQUIVALENTS, END OF PERIOD

$

4,310

$

$

4,310

RESTRICTED CASH, END OF PERIOD

20,535

20,535

CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD

$

24,845

$

$

24,845

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

Cash paid during the period for: Interest

$

16,042

$

$

16,042

Cash paid during the period for: Taxes

$

395

$

$

395

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:

Accrued development costs included in accounts payable and accrued expenses

$

8,805

$

(8,805)

$

Capitalized amortization of deferred financing costs and warrants

$

3,580

$

(387)

$

3,193

Capitalized stock-based compensation expense

$

177

$

(55)

$

122

Loan forgiveness

$

243

$

$

243